McMichael Bryan J 4

4 · Coherus Oncology, Inc. · Filed Jan 26, 2026

AI-generated summary of this filing

Updated Jan 26, 2026

Coherus Oncology (CHRS) CFO Bryan J. McMichael Receives RSU/Option Awards

What Happened

Bryan J. McMichael, Chief Financial Officer of Coherus Oncology (CHRS), received equity awards on January 22, 2026: 112,500 restricted stock units (RSUs) and 225,000 derivative awards/options. Both grants were recorded at $0.00 purchase price (awards, not open-market purchases), so no cash changed hands at grant.

Key Details

Transaction date: January 22, 2026; Form 4 filed January 26, 2026 reporting these grants.
Award amounts and reported values:
- 112,500 RSUs @ $0.00 (Footnote F1)
- 225,000 derivative award/option-related shares @ $0.00 (Footnote F2)
Vesting/terms (footnotes):
- F1 (RSUs): 50% vest May 20, 2027; remaining 50% vest March 20, 2029, subject to continued service.
- F2 (options/derivative): 1/4 of the total vests on the one-year anniversary of Jan 22, 2026, then 1/48th of the total vests each subsequent month (standard multi-year monthly vesting), subject to continued service.
Shares owned after the transaction: not specified in the provided filing excerpt.
No sale or immediate disposition reported; these are time-based compensation awards.

Context

These are compensation grants (awards), not purchases or sales. Because they vest over time, they are typical retention/incentive awards and do not represent an immediate market buy or sell by the insider.
For retail investors, awarded RSUs/options signal management compensation alignment with shareholder value over future vesting periods but do not necessarily indicate near-term insider buying or selling.

Form 4

Period: 2026-01-22

Chief Financial Officer

Transactions

Award
Common Stock
[F1]
2026-01-22+112,500→ 133,736 total
Award
Stock Option (Right to Buy)
[F2]
2026-01-22+225,000→ 225,000 total
Exercise: $1.59Exp: 2036-01-22→ Common Stock (225,000 underlying)

Footnotes (2)

[F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on May 20, 2027 and 50% of the RSUs vest on March 20, 2029, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
[F2]The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 22, 2026 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.

Signature

/s/ Bryan J. McMichael|2026-01-26

1 file